Our Therapeutic Focus Bipolar Depression & Suicidality Bipolar disorder is an illness that affects approximately 7 million individuals in the USA1. It can cause notable changes in a person’s mood, energy and ability to think clearly. People with bipolar disorder experience high and low moods—known as mania (highs) and depression (lows). These common, severe mood […]
NRX-100 is an IV ketamine formulation being submitted to regulators as an alternative treatment for acute suicidal crises in certain types of depression.
Dr. Andrew Nierenberg has been at the Massachusetts General Hospital since 1992, where he holds his current positions. He is also Honorary Professor in the School of Medicine, Faculty of Health at Deakin University, Geelong Australia.
Michael Taylor has over 25 years of experience in global credit markets, specializing in special situations, capital formation, and complex debt structuring.
Prof. Brown studies the mechanisms of Transcranial Magnetic Stimulation (TMS) and its clinical applications as Medical Director of McLean Hospital’s TMS Service.
